Steverink, Jasper G.
Bruins, Suzanne
van Tol, Floris R.
Jonkman, Hein R.
Amponsah, Kwame B.
Marvela, Jessica
Smorenburg, Andre J.
Oosterman, Bas J.
Piluso, Susanna
Verlaan, Jorrit-Jan
Article History
Received: 14 June 2025
Accepted: 27 August 2025
First Online: 2 September 2025
Competing interests
: This study describes in vivo pharmacokinetic and safety results as part of a drug development program. Authors JS, SB, FT, HJ, KA, JM, AS, BO, SP and JJV are all employees and/or own stocks in the SentryX company. JS, BO, SP and JJV are inventors of (U.S.) patent WO2020249695A1 covering hydrogel for in vivo release of medication.